NMC Health Plc Regarding Press Speculation (9451Y)
28 August 2018 - 4:01PM
UK Regulatory
TIDMNMC
RNS Number : 9451Y
NMC Health Plc
28 August 2018
28 August 2018
NMC Health plc
(the "Company" or "NMC")
Regarding Press Speculation
NMC Health plc (LSE: NMC), the leading private healthcare
operator in the Gulf Cooperation Council (GCC) with international
services across 17 countries, announces that The Company has taken
note of questions it has been receiving on the back of various news
articles regarding acquisition of assets in India. NMC denies such
news and reaffirms its current focus on the GCC market for capital
deployment. The Fertility business and O&M vertical remain the
only exceptions to the above and maintain a wider geographic
focus.
Contacts
Investors:
NMC Health
Prasanth Manghat, Chief Executive
Officer +971 50 522 5648
Prashanth Shenoy, Chief Financial
Officer +971 56 329 0545
Asjad Yayha, Investor Relations +971 56 219 0975
Media:
FTI Consulting, London
Brett Pollard +44 203 727 1000
FTI Consulting, Gulf
Shane Dolan +971 4 437 2100
About NMC Health
NMC the leading private healthcare operator in the GCC with an
international network of hospitals across 17 countries. NMC also
ranks as one of the top 3 in-vitro fertilisation ("IVF") operators
globally. The Group is also a leading provider of long-term medical
care in the UAE through its subsidiary ProVita. Pursing an
aggressive international expansion program from 2016, the company
now has over 34% of its licensed bed capacity in the Kingdom of
Saudi Arabia (KSA), where the company has introduced long-term and
multi-specialty care services. Moreover, the recent formation of a
joint venture with GOSI/Hassana Investment Company is set to
substantially boost the Group's bed capacity in KSA, with the JV
expected to be the second largest healthcare operator in the
Kingdom in terms of number of beds. NMC received over 5.7m patients
in 2017. The Group is also a leading UAE supplier of products and
consumables across several key market segments, with the major
contribution coming from healthcare related products. The Group
reported revenues of US$1.6 billion for the year ended 31 December
2017.
In April 2012 NMC was listed on the Premium Segment of the
London Stock Exchange. NMC is a constituent of the FTSE 100
Index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
SPCFKFDBPBKKPFB
(END) Dow Jones Newswires
August 28, 2018 02:01 ET (06:01 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Nmc Health Plc (London Stock Exchange): 0 recent articles
More Nmc Health News Articles